Details
Stereochemistry | RACEMIC |
Molecular Formula | C20H29FN6O3 |
Molecular Weight | 420.4811 |
Optical Activity | ( + / - ) |
Defined Stereocenters | 2 / 2 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CCN1N=NN(CCN2CC[C@@H]([C@H](C)C2)N(C(=O)COC)C3=CC=CC=C3F)C1=O
InChI
InChIKey=KKMGCTVJCQYQPV-WBVHZDCISA-N
InChI=1S/C20H29FN6O3/c1-4-25-20(29)26(23-22-25)12-11-24-10-9-17(15(2)13-24)27(19(28)14-30-3)18-8-6-5-7-16(18)21/h5-8,15,17H,4,9-14H2,1-3H3/t15-,17+/m1/s1
Molecular Formula | C20H29FN6O3 |
Molecular Weight | 420.4811 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 2 / 2 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Brifentanii, a potent narcotic analgesic structurally similar to alfentanil, that was studied in clinical trials in the early 1990s. The effects of brifentanil are very similar to those of alfentanil, with strong but short lasting analgesia and sedation, and particularly notable itching and respiratory depression. Side effects of Brifentanii are similar to those of fentanyl itself, which include itching, nausea and potentially serious respiratory depression, which can be life-threatening.
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 17:54:27 GMT 2023
by
admin
on
Sat Dec 16 17:54:27 GMT 2023
|
Record UNII |
6GDT77PQBW
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C1506
Created by
admin on Sat Dec 16 17:54:27 GMT 2023 , Edited by admin on Sat Dec 16 17:54:27 GMT 2023
|
||
|
NCI_THESAURUS |
C241
Created by
admin on Sat Dec 16 17:54:27 GMT 2023 , Edited by admin on Sat Dec 16 17:54:27 GMT 2023
|
||
|
WIKIPEDIA |
List_of_fentanyl_analogues
Created by
admin on Sat Dec 16 17:54:27 GMT 2023 , Edited by admin on Sat Dec 16 17:54:27 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
BRIFENTANIL
Created by
admin on Sat Dec 16 17:54:27 GMT 2023 , Edited by admin on Sat Dec 16 17:54:27 GMT 2023
|
PRIMARY | Brifentanil (A-3331) is an opioid analgesic that is an analogue of fentanyl and was developed in the early 1990s. Brifentanil is most similar to highly potent, short-acting fentanyl analogues such as alfentanil. The effects of brifentanil are very similar to those of alfentanil, with strong but short lasting analgesia and sedation, and particularly notable itching and respiratory depression. | ||
|
6500
Created by
admin on Sat Dec 16 17:54:27 GMT 2023 , Edited by admin on Sat Dec 16 17:54:27 GMT 2023
|
PRIMARY | |||
|
DB09172
Created by
admin on Sat Dec 16 17:54:27 GMT 2023 , Edited by admin on Sat Dec 16 17:54:27 GMT 2023
|
PRIMARY | |||
|
DTXSID20143867
Created by
admin on Sat Dec 16 17:54:27 GMT 2023 , Edited by admin on Sat Dec 16 17:54:27 GMT 2023
|
PRIMARY | |||
|
60672
Created by
admin on Sat Dec 16 17:54:27 GMT 2023 , Edited by admin on Sat Dec 16 17:54:27 GMT 2023
|
PRIMARY | |||
|
6GDT77PQBW
Created by
admin on Sat Dec 16 17:54:27 GMT 2023 , Edited by admin on Sat Dec 16 17:54:27 GMT 2023
|
PRIMARY | |||
|
100000088644
Created by
admin on Sat Dec 16 17:54:27 GMT 2023 , Edited by admin on Sat Dec 16 17:54:27 GMT 2023
|
PRIMARY | |||
|
CHEMBL2220476
Created by
admin on Sat Dec 16 17:54:27 GMT 2023 , Edited by admin on Sat Dec 16 17:54:27 GMT 2023
|
PRIMARY | |||
|
C79775
Created by
admin on Sat Dec 16 17:54:27 GMT 2023 , Edited by admin on Sat Dec 16 17:54:27 GMT 2023
|
PRIMARY | |||
|
BRIFENTANYL
Created by
admin on Sat Dec 16 17:54:27 GMT 2023 , Edited by admin on Sat Dec 16 17:54:27 GMT 2023
|
PRIMARY | |||
|
SUB05888MIG
Created by
admin on Sat Dec 16 17:54:27 GMT 2023 , Edited by admin on Sat Dec 16 17:54:27 GMT 2023
|
PRIMARY | |||
|
101345-71-5
Created by
admin on Sat Dec 16 17:54:27 GMT 2023 , Edited by admin on Sat Dec 16 17:54:27 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
SALT/SOLVATE -> PARENT | |||
|
TARGET -> AGONIST |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |